Charlson FJ, Ferrari AJ, Santomauro DF, Diminic S, Stockings E, Scott JG, et al. Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016. Schizophr Bull. 2018;44:1195–203.

Article  PubMed  PubMed Central  Google Scholar 

Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull. 1996;22:353–70.

Article  CAS  PubMed  Google Scholar 

Fusar-Poli P. The Clinical High-Risk State for Psychosis (CHR-P), Version II. Schizophr Bull. 2017;43:44–7.

Article  PubMed  Google Scholar 

Carrión RE, McLaughlin D, Goldberg TE, Auther AM, Olsen RH, Olvet DM, et al. Prediction of functional outcome in individuals at clinical high risk for psychosis. JAMA Psychiatry. 2013;70:1133–42.

Article  PubMed  PubMed Central  Google Scholar 

Michel C, Ruhrmann S, Schimmelmann BG, Klosterkötter J, Schultze-Lutter F. Course of clinical high-risk states for psychosis beyond conversion. Eur Arch Psychiatry Clin Neurosci. 2018;268:39–48.

Article  PubMed  Google Scholar 

Hartmann JA, Yuen HP, McGorry PD, Yung AR, Lin A, Wood SJ, et al. Declining transition rates to psychotic disorder in ‘ultra-high risk’ clients: Investigation of a dilution effect. Schizophr Res. 2016;170:130–6.

Article  PubMed  Google Scholar 

Andreou C, Borgwardt S. Structural and functional imaging markers for susceptibility to psychosis. Mol Psychiatry. 2020;25:2773–85.

Article  PubMed  PubMed Central  Google Scholar 

Ellis JK, Walker EF, Goldsmith DR. Selective Review of Neuroimaging Findings in Youth at Clinical High Risk for Psychosis: On the Path to Biomarkers for Conversion. Front Psychiatry. 2020;11:567534.

Article  PubMed  PubMed Central  Google Scholar 

Del Re EC, Stone WS, Bouix S, Seitz J, Zeng V, Guliano A, et al. Baseline Cortical Thickness Reductions in Clinical High Risk for Psychosis: Brain Regions Associated with Conversion to Psychosis Versus Non-Conversion as Assessed at One-Year Follow-Up in the Shanghai-At-Risk-for-Psychosis (SHARP) Study. Schizophr Bull. 2021;47:562–74.

Article  PubMed  Google Scholar 

Chung Y, Allswede D, Addington J, Bearden CE, Cadenhead K, Cornblatt B, et al. Cortical abnormalities in youth at clinical high-risk for psychosis: Findings from the NAPLS2 cohort. NeuroImage: Clinical. 2019;23:101862.

Article  PubMed  Google Scholar 

Fusar-Poli P, Crossley N, Woolley J, Carletti F, Perez-Iglesias R, Broome M, et al. Gray matter alterations related to P300 abnormalities in subjects at high risk for psychosis: Longitudinal MRI-EEG study. NeuroImage. 2011;55:320–8.

Article  PubMed  Google Scholar 

Damme KSF, Gupta T, Nusslock R, Bernard JA, Orr JM, Mittal VA. Cortical Morphometry in the Psychosis Risk Period: A Comprehensive Perspective of Surface Features. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019;4:434–43.

PubMed  Google Scholar 

Vissink CE, Winter-van Rossum I, Cannon TD, Fusar-Poli P, Kahn RS, Bossong MG. Structural Brain Volumes of Individuals at Clinical High Risk for Psychosis: A Meta-analysis. Biol Psychiatry Glob Open Sci. 2021;2:147–52.

Article  PubMed  PubMed Central  Google Scholar 

ENIGMA Clinical High Risk for Psychosis Working Group, Jalbrzikowski M, Hayes RA, Wood SJ, Nordholm D, Zhou JH, et al. Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis. JAMA Psychiatry. 2021;78:753–66.

Article  Google Scholar 

Bethlehem RaI, Seidlitz J, White SR, Vogel JW, Anderson KM, Adamson C, et al. Brain charts for the human lifespan. Nature. 2022;604:525–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peters BD, Karlsgodt KH. White matter development in the early stages of psychosis. Schizophr Res. 2015;161:61–9.

Article  PubMed  Google Scholar 

Koutsouleris N, Gaser C, Bottlender R, Davatzikos C, Decker P, Jäger M, et al. Use of neuroanatomical pattern regression to predict the structural brain dynamics of vulnerability and transition to psychosis. Schizophr Res. 2010;123:175–87.

Article  PubMed  Google Scholar 

Ziermans TB, Schothorst PF, Schnack HG, Koolschijn PCMP, Kahn RS, van Engeland H, et al. Progressive structural brain changes during development of psychosis. Schizophr Bull. 2012;38:519–30.

Article  PubMed  Google Scholar 

Cannon TD, Chung Y, He G, Sun D, Jacobson A, van Erp TGM, et al. Progressive Reduction in Cortical Thickness as Psychosis Develops: A Multisite Longitudinal Neuroimaging Study of Youth at Elevated Clinical Risk. Biol Psychiatry. 2015;77:147–57.

Article  PubMed  Google Scholar 

Merritt K, Luque Laguna P, Irfan A, David AS. Longitudinal Structural MRI Findings in Individuals at Genetic and Clinical High Risk for Psychosis: A Systematic Review. Front Psychiatry. 2021;12:620401.

Article  PubMed  PubMed Central  Google Scholar 

Collins MA, Ji JL, Chung Y, Lympus CA, Afriyie-Agyemang Y, Addington JM, et al. Accelerated cortical thinning precedes and predicts conversion to psychosis: The NAPLS3 longitudinal study of youth at clinical high-risk. Mol Psychiatry. 2023;28:1182–9.

Article  CAS  PubMed  Google Scholar 

Haijma SV, Van Haren N, Cahn W, Koolschijn PCMP, Hulshoff Pol HE, Kahn RS. Brain Volumes in Schizophrenia: A Meta-Analysis in Over 18 000 Subjects. Schizophrenia Bulletin. 2013;39:1129–38.

Article  PubMed  Google Scholar 

Veijola J, Guo JY, Moilanen JS, Jääskeläinen E, Miettunen J, Kyllönen M, et al. Longitudinal Changes in Total Brain Volume in Schizophrenia: Relation to Symptom Severity, Cognition and Antipsychotic Medication. PLoS One. 2014;9:e101689.

Article  PubMed  PubMed Central  Google Scholar 

Rajkowska G, Selemon LD, Goldman-Rakic PS. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry. 1998;55:215–24.

Article  CAS  PubMed  Google Scholar 

Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry. 2000;57:65–73.

Article  CAS  PubMed  Google Scholar 

Pierri JN, Volk CL, Auh S, Sampson A, Lewis DA. Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry. 2001;58:466–73.

Article  CAS  PubMed  Google Scholar 

Sweet RA, Pierri JN, Auh S, Sampson AR, Lewis DA. Reduced pyramidal cell somal volume in auditory association cortex of subjects with schizophrenia. Neuropsychopharmacology. 2003;28:599–609.

Article  PubMed  Google Scholar 

Sweet RA, Henteleff RA, Zhang W, Sampson AR, Lewis DA. Reduced Dendritic Spine Density In Auditory Cortex Of Subjects With Schizophrenia. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology. Neuropsychopharmacology. 2009;34:374.

Article  PubMed  Google Scholar 

Garey LJ, Ong WY, Patel TS, Kanani M, Davis A, Mortimer AM, et al. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry. 1998;65:446–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shelton MA, Newman JT, Gu H, Sampson AR, Fish KN, MacDonald ML, et al. Loss of Microtubule-Associated Protein 2 Immunoreactivity Linked to Dendritic Spine Loss in Schizophrenia. Biol Psychiatry. 2015;78:374–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Konopaske GT, Lange N, Coyle JT, Benes FM. Prefrontal Cortical Dendritic Spine Pathology in Schizophrenia and Bipolar Disorder. JAMA Psychiatry. 2014;71:1323.

Article  PubMed  PubMed Central  Google Scholar 

Harrison PJ. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain. 1999;122:593–624.

Article